• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

H1 Launches AI-Powered and Evidence-Based Interactions

by Syed Hamza Sohail 08/11/2022 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
H1 Launches AI-Powered and Evidence-Based Interactions

What You Should Know:

– H1, launches an update to its flagship product, HCP Universe, the daily resource for global medical affairs and medical science liaison (MSL) teams.

– New features include a mobile app, Next-gen Smart Search capabilities built on an expansive knowledge graph, out-of-the-box insights tailored to inform MSL and Headquarter decisioning, and AI-powered notifications to improve and accelerate quality HCP engagement. 

Establishing AI-Driven Efficient Workflows

H1 is the connecting force for global HCP, clinical, scientific and research information. The H1 Connect platform democratizes access to HCP knowledge and groundbreaking insights for life sciences, academic medical institutions, health systems, and payors. H1 Connect fuels a robust product suite that helps customers discover and engage industry experts, drive equitable research, access groundbreaking science, and accelerate commercial success with the most robust and accurate healthcare professional data.


HCP Universe is built on the H1 Connect platform, which seamlessly blends H1 proprietary, public, industry, and self-reported HCP information and patient encounter data. The latest AI and Data Science technologies are then layered on the H1 Data Network to fit the unique workflows of key stakeholders across Pharma and Biotech companies. A subset of the AI-enabled features that will be available to customers this year include:  

1. Integration with Calendars (i.e., Outlook) and Proactive Mobile Text Notifications: A new and improved notification and alert framework that integrates with work calendars and provides proactive alerts and updates about HCPs before their next scheduled meeting. Signals include tweets, publications, congresses, and clinical trial data for initiating outreach. 

2. Smart Search and Discovery: A completely re-designed KOL network exploration interface that helps MSLs easily uncover HCP connections, identify HCPs that work well together, compare and contrast HCPs, and determine if HCPs meet certain criteria. Customizable, one-click search filters can reveal unique HCP segments like prolific publishers, early career influencers, and industry speakers. 

3. Digital Activity and Leadership Monitoring: Users can explore and understand an HCP’s social network in conjunction with their academic and research collaborations. H1 has developed a unique and AI-based technological algorithm to find Therapeutic Area (TA) digital opinion leaders (DOLs), specialized in individual areas of interest. Users can quickly identify DOLs within a given indication or TA and categorize through indexing of followers and other profile-level metadata to derive a digital leadership score.

“According to a recent study by ZS Associates, Medical Affairs leaders surveyed claim medical analytics and more specifically AI and NLP are among their top areas of investments. While H1 has long been recognized as having the most comprehensive mix of HCP data available – this evolution of our application of AI, NLP and Machine Learning transforms the way our customers extract 360-degree insights on global HCPs and KOLs and the patient populations they serve,” said Katz. “Without HCP Universe, corporate Medical Affairs teams and field MSLs are forced to spend too much time and effort consuming, analyzing, and synthesizing data for each individual engagement. Moreover, unvetted information can be outdated, incomplete or overlapping. This results in lost opportunities to connect and cultivate relationships with the right medical experts. Our revamped HCP Universe changes all that.”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: AI, Artificial Intelligence, Biotech, Box, Clinical Trial, H1, Health Systems, Knowledge Graph, Life Sciences, Machine Learning, NLP, Pharma

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |